Module 1 is the only part of the CTD that is not harmonised internationally, and it is where many otherwise strong dossiers stumble. For EU submissions, it is also where the electronic application form now plays a central role, with mandatory use of the web-based eAF for centrally authorised product variations from 1 September 2026.
What EU Module 1 covers
The EU Module 1 specification sets out the regional content that accompanies the harmonised CTD. Key sections include:
- the cover letter and the application form (1.2);
- product information (1.3): SmPC, labelling and package leaflet texts, mock-ups and the results of consultation with target patient groups;
- information about the experts who sign the quality, nonclinical and clinical overviews (1.4);
- specific requirements for different application types (1.5), the environmental risk assessment (1.6) and orphan market exclusivity information where relevant (1.7);
- pharmacovigilance information, including the summary of the pharmacovigilance system and the risk management plan (1.8);
- clinical trial information (1.9) and paediatric information (1.10).
The web-based eAF
The electronic application form is now completed through EMA’s Product Lifecycle Management (PLM) portal, drawing on structured product and organisation data. EMA has strongly recommended the web-based form since July 2024 and has announced mandatory use for centrally authorised products from 1 September 2026. From that date, human CAP variation submissions using the older interactive PDF form are expected to be rejected unless a valid, justified technical reason is given. Use of the web-based form for nationally authorised products is also being promoted through the CMDh and national authorities.
Data quality matters more than ever
Because the web-based eAF pulls from the Product Management Service (PMS) and Organisation Management Service (OMS), errors in master data now flow directly into the application. Before filing, check that:
- organisation records for the applicant, manufacturers and batch release sites are current in OMS;
- product data in PMS reflect the authorised status;
- the information in the form matches Module 3 and the product information exactly.
Greek national particulars
For decentralised, mutual recognition and national procedures involving Greece, EOF applies its own national requirements, including Greek-language product information and national administrative documents. These sit alongside the EU Module 1 framework and should be confirmed against EOF’s current guidance for each submission.
How PQRA helps
PQRA prepares EU and Greek Module 1 packages, supports completion of the web-based eAF and checks that PMS and OMS data are aligned with the dossier before submission.
Contact PQRA to discuss your next dossier.


No responses yet